They also showed that the heat shock protein 90 (Hsp90) inhibitor geldanamycin, a known inhibitor of the HGF/MET pathway [73], increased apoptosis, and decreased motility and MET expression in SCLC cell lines. This evidence concerns the gene MET and small cell lung carcinoma.